Category: Uncategorized

Jul 09 2026

Uncategorized

When Dysphagia Is Not Psychogenic: An Atypical Presentation of Schatzki Ring in a Patient With Schizophrenia – Cureus

by Clinical Editor

No Comments

When Dysphagia Is Not Psychogenic: An Atypical Presentation of Schatzki Ring in a Patient With Schizophrenia  Cureus

Jul 09 2026

Uncategorized

How to Navigate Recovery in Schizophrenia

by Clinical Editor

No Comments

In addition to a prescribing clinician, sometimes a person with schizophrenia will work with a counselor and or a psychologist for talk therapy. Others may benefit from a case manager....

Jul 08 2026

Uncategorized

TG Therapeutics Launches Phase 2 Trial of BRIUMVI in Treatment-Resistant Schizophrenia – The Clinical Trial Vanguard

by Clinical Editor

No Comments

TG Therapeutics Launches Phase 2 Trial of BRIUMVI in Treatment-Resistant Schizophrenia  The Clinical Trial Vanguard

Jul 08 2026

Uncategorized

Preconception Maternal Trauma Doubles Schizophrenia Risk – Neuroscience News

by Clinical Editor

No Comments

Preconception Maternal Trauma Doubles Schizophrenia Risk  Neuroscience News

Jul 07 2026

Uncategorized

Study reveals long-term, intergenerational impacts of severe preconception trauma

by Clinical Editor

No Comments

Can the trauma of a parent rewrite the mental health of a child born decades later? A new compelling study reveals that children born decades after the Holocaust to parents...

Jul 07 2026

Uncategorized

Schizophrenia and bipolar disorder share 70% of their genetic roots, landmark study finds

by Clinical Editor

No Comments

(Kateryna Kon/Science Photo Library/Getty Images) Researchers are beginning to realize that even vastly different psychiatric disorders can share startlingly similar genetic roots. In February last …

Jul 06 2026

Uncategorized

TG Therapeutics Announces Initiation of Phase 2 Trial – GlobeNewswire

by Clinical Editor

No Comments

TG Therapeutics Announces Initiation of Phase 2 Trial  GlobeNewswire

Jul 06 2026

Uncategorized

Québec is the first province to list (Pr)OKEDI(MC) (extended-release injectable suspension of risperidone) on the public drug reimbursement formulary for the treatment of schizophrenia – Yahoo! Finance Canada

by Clinical Editor

No Comments

Québec is the first province to list (Pr)OKEDI(MC) (extended-release injectable suspension of risperidone) on the public drug reimbursement formulary for the treatment of schizophrenia  Yahoo! Finance Canada

Jul 04 2026

Uncategorized

Identification of hub genes involved in early-onset schizophrenia: from genetic susceptibility to predicted regulated gene expression – Nature

by Clinical Editor

No Comments

Identification of hub genes involved in early-onset schizophrenia: from genetic susceptibility to predicted regulated gene expression  Nature

Jul 02 2026

Uncategorized

Novel Mechanisms of Action in Schizophrenia Treatment – Psychiatric Times

by Clinical Editor

No Comments

Novel Mechanisms of Action in Schizophrenia Treatment  Psychiatric Times